Frazier Lifesciences Acquisition Statistics Share Statistics Frazier Lifesciences Acquisition has n/a
shares outstanding. The number of shares has increased by null%
in one year.
Shares Outstanding n/a Shares Change (YoY) n/a Shares Change (QoQ) n/a Owned by Institutions (%) n/a Shares Floating n/a Failed to Deliver (FTD) Shares n/a FTD / Avg. Volume n/a
Short Selling Information The latest short interest is 6.68K, so 0% of the outstanding
shares have been sold short.
Short Interest 6.68K Short % of Shares Out n/a Short % of Float n/a Short Ratio (days to cover) 1.09
Valuation Ratios The PE ratio is 17.77 and the forward
PE ratio is null.
Frazier Lifesciences Acquisition's PEG ratio is
0.
PE Ratio 17.77 Forward PE n/a PS Ratio 0 Forward PS n/a PB Ratio 1.31 P/FCF Ratio -1250.72 PEG Ratio 0
Financial Ratio History Enterprise Valuation Frazier Lifesciences Acquisition has an Enterprise Value (EV) of 171.85M.
EV / Sales 0 EV / EBITDA 40.96 EV / EBIT -1241.86 EV / FCF -1241.86
Financial Position The company has a current ratio of 6.7,
with a Debt / Equity ratio of 0.
Current Ratio 6.7 Quick Ratio 6.7 Debt / Equity 0 Debt / EBITDA n/a Debt / FCF n/a Interest Coverage -84.54
Financial Efficiency Return on Equity is 7.4% and Return on Invested Capital is -2.29%.
Return on Equity 7.4% Return on Assets 6.98% Return on Invested Capital -2.29% Revenue Per Employee n/a Profits Per Employee n/a Employee Count undefined Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax -5.56M Effective Tax Rate -133.07%
Stock Price Statistics The stock price has increased by 0% in the
last 52 weeks. The beta is 0, so Frazier Lifesciences Acquisition's
price volatility has been lower than the market average.
Beta 0 52-Week Price Change n/a 50-Day Moving Average 10.07 200-Day Moving Average n/a Relative Strength Index (RSI) 41.87 Average Volume (20 Days) 4,493
Income Statement
Revenue n/a Gross Profit n/a Operating Income -1.37M Net Income 9.74M EBITDA 4.2M EBIT 4.2M Earnings Per Share (EPS) 0.55
Full Income Statement Balance Sheet The company has 1.23M in cash and 0 in
debt, giving a net cash position of 1.23M.
Cash & Cash Equivalents 1.23M Total Debt n/a Net Cash n/a Retained Earnings -6.36M Total Assets n/a Working Capital n/a
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -138.38K
and capital expenditures 0, giving a free cash flow of -138.38K.
Operating Cash Flow -138.38K Capital Expenditures n/a Free Cash Flow -138.38K FCF Per Share -0.01
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
